Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial

Elliott RA, Payne K, Moore JK, Davies LM, Harper NJ, St. Leger AS, Moore EW, Thoms GM, Pollard BJ, McHugh GA, Bennett J, Lawrence G, Kerr J
Record ID 32003000434
Authors' objectives:

The objectives were to identify and value resource use, impact on patients and relative value for money associated with different anaesthetic agents in day surgery.

Authors' recommendations: The main conclusions are: - Sevoflurane/sevoflurane is not a cost-effective regimen for day surgery in adults or children. It is associated with higher rates of postoperative nausea and vomiting (PONV) than propofol followed by propofol, isoflurane or sevoflurane. It is more expensive than mixed anaesthesia regimens. - In the adult study, there were no statistically significant differences in the incidence of PONV between the regimens that used propofol for induction. However, there were statistically significant differences in the variable costs of the regimens. The propofol/isoflurane regimen was associated with the lowest cost per episode of PONV avoided.
Authors' methods: Systematic review, survey, randomised controlled trial
Project Status: Completed
URL for project: http://www.hta.ac.uk/1077
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Adult
  • Ambulatory Surgical Procedures
  • Anesthetics
  • Child
  • Costs and Cost Analysis
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: 2002 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.